List of works - Barbara Girerd

A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents

scientific article published on 12 July 2012

A novel channelopathy in pulmonary arterial hypertension

scientific article published on July 2013

A proof of concept for the detection and classification of pulmonary arterial hypertension through breath analysis with a sensor array

scientific article published in September 2013

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.

scientific article

BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.

scientific article

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

scientific article

Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.

scientific article published on 16 March 2016

C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.

scientific article

Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2.

scientific article published in May 2015

Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension

scientific article published in October 2018

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

scientific article published on 20 March 2008

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation

scientific article published on 7 January 2010

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

scientific article published on 10 January 2017

Cytotoxic Cells and Granulysin in Pulmonary Arterial Hypertension and Pulmonary Veno-occlusive Disease

scientific article published on 06 December 2012

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules

scientific article (publication date: 24 January 2017)

Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension

scientific article published on 13 September 2013

Does Circulating IL-17 Identify a Subset of Patients With Idiopathic Pulmonary Arterial Hypertension?: Response

scientific article published on 01 October 2015

EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.

scientific article published in December 2013

Familial pulmonary arterial hypertension by KDR heterozygous loss of function

scientific article published on 03 April 2020

Genetic counselling in a national referral centre for pulmonary hypertension.

scientific article published on 23 December 2015

Genetic determinants of risk and survival in pulmonary arterial hypertension

article

Genetics of pulmonary hypertension in the clinic

scientific article published on 28 June 2017

Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

scientific article published on 17 March 2013

Gut-Lung Connection in Pulmonary Arterial Hypertension.

scientific article published in March 2017

Heritable pulmonary hypertension: from bench to bedside

scientific article published on 6 September 2017

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

scientific article published on 12 April 2018

KCNK3: new gene target for pulmonary hypertension?

scientific article published on 18 April 2014

Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension

scientific article published on 23 February 2012

Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension

scientific article published on 01 October 2018

Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations

scientific article published on 19 August 2014

Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models

scientific article published on 30 June 2015

Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study.

scientific article

Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 Mutations

scientific article published on 01 August 2018

New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication

scientific article

Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension.

scientific article published on 04 October 2013

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease

scientific article published on 5 November 2015

P130Cas-Dependent Reversal Of Pulmonary Arterial Muscularization By Imatinib, Gefitinib And Dovitinib

Phenotype and outcome of PAH patients carrying a TBX4 mutation

scientific article published on 20 February 2020

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension

scientific article published on 28 September 2017

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.

scientific article published on 14 June 2017

Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.

scientific article published on 24 February 2016

Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation.

scientific article

Pulmonary Arterial Hypertension in a Patient With Cowden Syndrome and Anorexigen Exposure

scientific article published on 01 October 2011

Pulmonary arterial hypertension

scientific article published on 06 July 2013

Pulmonary arterial hypertension in familial hemiplegic migraine with ATP1A2 channelopathy

scientific article published on 17 October 2013

Pulmonary arterial hypertension in patients treated by dasatinib

scientific article

Pulmonary capillary haemangiomatosis: a distinct entity?

scientific article published on 27 May 2020

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension

scientific article published on 19 May 2017

Pulmonary hypertension associated with neurofibromatosis type 1

scientific article published on 29 August 2018

Pulmonary hypertension in patients with neurofibromatosis type I.

scientific article published in May 2011

Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension

scientific article published on 22 November 2011

Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.

scientific article published on 4 October 2017

Pulmonary veno-occlusive disease

scientific article published on 23 March 2016

Pulmonary veno-occlusive disease: advances in clinical management and treatments

scientific article published on April 2011

Response to Letter Regarding Article, “Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model”

scientific article published on 01 April 2016

Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.

scientific article published on 5 May 2016

Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension

scientific article published in August 2015

Screening for pulmonary arterial hypertension in adults carrying a <i>BMPR2</i> mutation

scientific article published on 30 December 2020

Small platelet microparticle levels are increased in pulmonary arterial hypertension.

scientific article

T-helper 17 cell polarization in pulmonary arterial hypertension

scientific article published in June 2015

Targeted therapies in pulmonary arterial hypertension

scientific article published on 14 October 2013

Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension

scientific article published on 25 April 2015

Ventilation/perfusion lung scan in pulmonary veno-occlusive disease

scientific article published on 16 November 2011

Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases

scientific article published on 14 March 2019

List of works by Barbara Girerd

A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents

A novel channelopathy in pulmonary arterial hypertension

A proof of concept for the detection and classification of pulmonary arterial hypertension through breath analysis with a sensor array

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.

BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.

C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.

Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2.

Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

Cytotoxic Cells and Granulysin in Pulmonary Arterial Hypertension and Pulmonary Veno-occlusive Disease

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules

Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension

Does Circulating IL-17 Identify a Subset of Patients With Idiopathic Pulmonary Arterial Hypertension?: Response

EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.

Familial pulmonary arterial hypertension by KDR heterozygous loss of function

Genetic counselling in a national referral centre for pulmonary hypertension.

Genetic determinants of risk and survival in pulmonary arterial hypertension

Genetics of pulmonary hypertension in the clinic

Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

Gut-Lung Connection in Pulmonary Arterial Hypertension.

Heritable pulmonary hypertension: from bench to bedside

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

KCNK3: new gene target for pulmonary hypertension?

Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension

Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension

Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations

Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models

Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study.

Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 Mutations

New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication

Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension.

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease

P130Cas-Dependent Reversal Of Pulmonary Arterial Muscularization By Imatinib, Gefitinib And Dovitinib

Phenotype and outcome of PAH patients carrying a TBX4 mutation

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.

Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.

Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation.

Pulmonary Arterial Hypertension in a Patient With Cowden Syndrome and Anorexigen Exposure

Pulmonary arterial hypertension

Pulmonary arterial hypertension in familial hemiplegic migraine with ATP1A2 channelopathy

Pulmonary arterial hypertension in patients treated by dasatinib

Pulmonary capillary haemangiomatosis: a distinct entity?

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension

Pulmonary hypertension associated with neurofibromatosis type 1

Pulmonary hypertension in patients with neurofibromatosis type I.

Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension

Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.

Pulmonary veno-occlusive disease

Pulmonary veno-occlusive disease: advances in clinical management and treatments

Response to Letter Regarding Article, “Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model”

Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.

Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension

Screening for pulmonary arterial hypertension in adults carrying a <i>BMPR2</i> mutation

Small platelet microparticle levels are increased in pulmonary arterial hypertension.

T-helper 17 cell polarization in pulmonary arterial hypertension

Targeted therapies in pulmonary arterial hypertension

Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension

Ventilation/perfusion lung scan in pulmonary veno-occlusive disease

Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases